Search

everythinglearnresearchcommunity

for

Search:↓

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Fractional lasers seem effective and safe for treating hair loss, but more research is needed to find the best treatment methods.

Finasteride reduces corpus cavernosum weight but doesn't affect erectile response in rats.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Oral minoxidil 5 mg daily increases hair growth safely in men with hair loss, with minor side effects.

Some plants with flavonoids may help treat hair loss and promote hair growth.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Herbal extracts may help hair grow and could be an alternative to synthetic hair loss treatments.

Finasteride can cause sexual problems and depression in young men.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Hair follicle culture helps develop new treatments for hair loss.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Probe detects finasteride with high selectivity and low detection limit.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Anabolic steroid users may face higher risk of severe COVID-19.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Vesicular carriers like liposomes may improve cosmetic skin treatment delivery and effectiveness but need more human research.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.